With millions of adults in the United States reporting an episode of gout symptoms after the age of 20, clinical scientists now recognize the importance of researching the causes and treatments of gout. Many pharmaceutical companies and clinical research centers are devoting significant resources into more gout research. New investigational therapies for gout may arise from improvements in existing classes of drugs, or from the development of novel therapies based on a better understanding of the underlying disease process.
Gout: Recent Research Breakthroughs
- New investigational treatments for gout – Recently FDA approved medications. Febuxostat for prevention of gout, and Pegloticase (Puricase) for the treatment of severe, refractory gout.
- Finding ways to use current treatments more effectively.
- Researching the role of diet in preventing and managing gout symptoms. A long term study has shown taking 1,500 milligrams of vitamin C a day reduced the risk of gout in men by 45 percent. Another research study reported that men who eat low-fat dairy cut the risk of Gout in half.
- Identifying genetic and environmental factors that may contribute to gout. Researchers have identified three genes that multiply gout risk.
- Research studies are underway seeking to understand the relationship between gout, high uric levels, and heart disease.